GRN Gene Ceroid Lipofuscinosis Neuronal Type 11 NGS Genetic DNA Test
Introduction
The GRN Gene Ceroid Lipofuscinosis Neuronal Type 11 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with neuronal ceroid lipofuscinosis (NCL), a group of metabolic disorders. This test employs Next Generation Sequencing (NGS) technology to analyze the GRN gene, which plays a crucial role in neuronal health.
What the Test Measures
This test specifically detects mutations in the GRN gene that may lead to neuronal ceroid lipofuscinosis neuronal type 11. It provides insights into the genetic basis of the disease, helping healthcare providers understand the risk factors involved.
Who Should Consider This Test
Individuals with a family history of Ceroid lipofuscinosis neuronal type 11 or those exhibiting symptoms such as:
- Progressive vision loss
- Seizures
- Cognitive decline
- Movement disorders
should consider undergoing this test. Genetic counseling is recommended to understand the implications of the results.
Benefits of Taking the Test
- Early diagnosis of genetic predispositions
- Informed decision-making regarding family planning
- Access to targeted therapies and management strategies
- Peace of mind for affected families
Understanding Your Results
Results from the GRN Gene Ceroid Lipofuscinosis Neuronal Type 11 NGS Genetic DNA Test will be available within 3 to 4 weeks. A genetic counselor will help interpret the findings and discuss the next steps based on your results.
Test Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| GRN Gene Ceroid Lipofuscinosis Neuronal Type 11 NGS Genetic DNA Test | 40,000 | 56,000 |
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu. Our team is ready to assist you with home sample collection services. Don’t wait any longer to gain insight into your genetic health. Call or WhatsApp us at +254711564616 to book your test today!
